|
1
|
Khazaei S, Rezaeian S, Soheylizad M,
Khazaei S and Biderafsh A: Global incidence and mortality rates of
stomach cancer and the human development index: An ecological
study. Asian Pac J Cancer Prev. 17:1701–1704. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sullivan R and Graham CH: Hypoxia-driven
selection of the metastatic phenotype. Cancer Metastasis Rev.
26:319–331. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vaupel P and Mayer A: Hypoxia in cancer:
Significance and impact on clinical outcome. Cancer Metastasis Rev.
26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu G, Yang G, Chang B, Mercado-Uribe I,
Huang M, Zheng J, Bast RC, Lin SH and Liu J: Stanniocalcin 1 and
ovarian tumorigenesis. J Natl Cancer Inst. 102:812–827. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tamura S, Oshima T, Yoshihara K, Kanazawa
A, Yamada T, Inagaki D, Sato T, Yamamoto N, Shiozawa M, Morinaga S,
et al: Clinical significance of STC1 gene expression in patients
with colorectal cancer. Anticancer Res. 31:325–329. 2011.PubMed/NCBI
|
|
6
|
Chang AC, Doherty J, Huschtscha LI,
Redvers R, Restall C, Reddel RR and Anderson RL: STC1 expression is
associated with tumor growth and metastasis in breast cancer. Clin
Exp Metastasis. 32:15–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang Z, Tian Z, Luo K, Song H and Yi J:
Clinical significance of stanniocalcin expression in tissue and
serum of gastric cancer patients. Chinese J Cancer Res. 26:602–610.
2014.
|
|
8
|
Zhang K, Lindsberg PJ, Tatlisumak T, Kaste
M, Olsen HS and Andersson LC: Stanniocalcin: A molecular guard of
neurons during cerebral ischemia. Proc Natl Acad Sci USA.
97:3637–3642. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yeung HY, Lai KP, Chan HY, Mak NK, Wagner
GF and Wong CK: Hypoxia-inducible factor-1-mediated activation of
stanniocalcin-1 in human cancer cells. Endocrinology.
146:4951–4960. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shroff EH, Snyder C and Chandel NS: Bcl-2
family members regulate anoxia-induced cell death. Antioxid Redox
Signal. 9:1405–1409. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu L, Ning X, Sun L, Zhang H, Shi Y, Guo
C, Han S, Liu J, Sun S, Han Z, et al: Hypoxia-inducible factor-1
alpha contributes to hypoxia-induced chemoresistance in gastric
cancer. Cancer Sci. 99:121–128. 2008.PubMed/NCBI
|
|
12
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA,
Reddel RR, et al: Check your cultures! A list of cross-contaminated
or misidentified cell lines. Int J Cancer. 127:1–8. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun T, Sun BC, Zhao XL, Zhao N, Dong XY,
Che N, Yao Z, Ma YM, Gu Q, Zong WK, et al: Promotion of tumor cell
metastasis and vasculogenic mimicry by way of transcription
coactivation by Bcl-2 and Twist1: a study of hepatocellular
carcinoma. Hepatology. 54:1690–1706. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Wang Z, Qi Z, Yin S, Zhang N, Liu
Y, Liu M, Meng J, Zang R, Zhang Z, et al: The negative interplay
between Aurora A/B and BRCA1/2 controls cancer cell growth and
tumorigenesis via distinct regulation of cell cycle progression,
cytokinesis, and tetraploidy. Mol Cancer. 13:942014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun H, Wang Y, Wang Z, Meng J, Qi Z and
Yang G: Aurora-A controls cancer cell radio- and chemoresistance
via ATM/Chk2-mediated DNA repair networks. Biochim Biophys Acta
1843. 934–944. 2014.
|
|
16
|
Hou J, Wang Z, Xu H, Yang L, Yu X, Yang Z,
Deng Y, Meng J, Feng Y, Guo X, et al: Stanniocalicin 2 suppresses
breast cancer cell migration and invasion via the
PKC/claudin-1-mediated signaling. PloS One. 10:e01221792015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Szasz AM, Lanczky A, Nagy A, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang W, Sun XW, Li CF, Lv L, Li YF, Chen
YB, Xu DZ, Kesari R, Huang CY, Li W, et al: Comparison of the 6th
and 7th editions of the UICC TNM staging system for gastric cancer:
Results of a Chinese single-institution study of 1,503 patients.
Ann Surg Oncol. 18:1060–1067. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Salnikow K, Donald SP, Bruick RK,
Zhitkovich A, Phang JM and Kasprzak KS: Depletion of intracellular
ascorbate by the carcinogenic metals nickel and cobalt results in
the induction of hypoxic stress. J Biol Chem. 279:40337–40344.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rath S, Anand A, Ghosh N, Das L, Kokate
SB, Dixit P, Majhi S, Rout N, Singh SP and Bhattacharyya A: Cobalt
chloride-mediated protein kinase Calpha (PKCalpha) phosphorylation
induces hypoxia-inducible factor 1alpha (HIF1alpha) in the nucleus
of gastric cancer cell. Biochem Biophys Res Commun. 471:205–212.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bai Y, Xiao Y, Dai Y, Chen X, Li D, Tan X
and Zhang X: Stanniocalcin 1 promotes cell proliferation via cyclin
E1/cyclin-dependent kinase 2 in human prostate carcinoma. Oncol
Rep. 37:2465–2471. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zuo J, Ishikawa T, Boutros S, Xiao Z,
Humtsoe JO and Kramer RH: Bcl-2 overexpression induces a partial
epithelial to mesenchymal transition and promotes squamous
carcinoma cell invasion and metastasis. Mol Cancer Res. 8:170–182.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Choi J, Choi K, Benveniste EN, Rho SB,
Hong YS, Lee JH, Kim J and Park K: Bcl-2 promotes invasion and lung
metastasis by inducing matrix metalloproteinase-2. Cancer Res.
65:5554–5560. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sumiyoshi Y, Kakeji Y, Egashira A,
Mizokami K, Orita H and Maehara Y: Overexpression of
hypoxia-inducible factor 1alpha and p53 is a marker for an
unfavorable prognosis in gastric cancer. Clin Cancer Res.
12:5112–5117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu X and Kang Y: Hypoxia and
hypoxia-inducible factors: Master regulators of metastasis. Clin
Cancer Res. 16:5928–5935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lal A, Peters H, St Croix B, Haroon ZA,
Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ and
Riggins GJ: Transcriptional response to hypoxia in human tumors. J
Natl Cancer Inst. 93:1337–1343. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma X, Gu L, Li H, Gao Y, Li X, Shen D,
Gong H, Li S, Niu S, Zhang Y, et al: Hypoxia-induced overexpression
of stanniocalcin-1 is associated with the metastasis of early stage
clear cell renal cell carcinoma. J Transl Med. 13:562015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Law AY, Ching LY, Lai KP and Wong CK:
Identification and characterization of the hypoxia-responsive
element in human stanniocalcin-1 gene. Mol Cell Endocrinol.
314:118–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cornmark L, Lonne GK, Jogi A and Larsson
C: Protein kinase Calpha suppresses the expression of STC1 in
MDA-MB-231 breast cancer cells. Tumour Biol. 32:1023–1030. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nguyen A, Chang AC and Reddel RR:
Stanniocalcin-1 acts in a negative feedback loop in the prosurvival
ERK1/2 signaling pathway during oxidative stress. Oncogene.
28:1982–1992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi X, Wang J and Qin Y: Recombinant
adeno-associated virus-delivered hypoxia-inducible stanniocalcin-1
expression effectively inhibits hypoxia-induced cell apoptosis in
cardiomyocytes. J Cardiovasc Pharmacol. 64:522–529. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Westberg JA, Serlachius M, Lankila P,
Penkowa M, Hidalgo J and Andersson LC: Hypoxic preconditioning
induces neuroprotective stanniocalcin-1 in brain via IL-6
signaling. Stroke. 38:1025–1030. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu D, Shang H and Liu Y: Stanniocalcin-1
protects a mouse model from renal ischemia-reperfusion injury by
affecting ROS-mediated multiple signaling pathways. Int J Mol Sci.
17:E10512016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arigami T, Uenosono Y, Ishigami S,
Hagihara T, Haraguchi N, Matsushita D, Yanagita S, Nakajo A,
Okumura H, Hokita S, et al: Expression of stanniocalcin 1 as a
potential biomarker of gastric cancer. Oncology. 83:158–164. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He LF, Wang TT, Gao QY, Zhao GF, Huang YH,
Yu LK and Hou YY: Stanniocalcin-1 promotes tumor angiogenesis
through up-regulation of VEGF in gastric cancer cells. J Biomed
Sci. 18:392011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoon JH, Kim J, Kim KL, Kim DH, Jung SJ,
Lee H, Ghim J, Kim D, Park JB, Ryu SH, et al: Proteomic analysis of
hypoxia-induced U373MG glioma secretome reveals novel
hypoxia-dependent migration factors. Proteomics. 14:1494–1502.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
An J, Lv J, Li A, Qiao J, Fang L, Li Z, Li
B, Zhao W, Chen H and Wang L: Constitutive expression of Bcl-2
induces epithelial-Mesenchymal transition in mammary epithelial
cells. BMC Cancer. 15:4762015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Leng J, Song Q, Zhao Y and Wang Z: miR15a
represses cancer cell migration and invasion under conditions of
hypoxia by targeting and downregulating Bcl2 expression in human
osteosarcoma cells. Int J Oncol. 52:1095–1104. 2018.PubMed/NCBI
|
|
39
|
Duan Y, He Q, Yue K, Si H, Wang J, Zhou X
and Wang X: Hypoxia induced Bcl-2/Twist1 complex promotes tumor
cell invasion in oral squamous cell carcinoma. Oncotarget.
8:7729–7739. 2017. View Article : Google Scholar : PubMed/NCBI
|
